Life science organizations in the U.S. operate in one of the most rigorously regulated industries in the world. Read More
Have you lost the hybridoma for your key research antibody? Has batch-to-batch variability made your research irreproducible? Are engineering your antibodies into therapeutic candidates? Read More
As a bioentrepreneur in the highest stakes arena of any industry, if you are treating your innovation’s path to market with antiquated methods, you miss out on an advantage over your competition. Read More
Cybersecurity is a growing threat in the Life Sciences Industry. This whitepaper takes a deep dive into the risks that are challenging the Life Sciences sector, and how to best mitigate those risks. Read More
Antibodies are an invaluable tool in the life sciences, however, despite their importance, many antibodies are experiencing the reproducibility crisis; researchers are using REmAb™ to overcome this. Read More
https://massbiotechboom.com Read More
Data integrity is of paramount importance to ensure patient health and safety and to improve shareholder value. Read More
In the 2019 edition of our Life Sciences and Health Care Horizons publication, our global team identifies a number of current and evolving trends that are shaping the future of the industry. Read More
A successful product development strategy requires a comprehensive understanding of the market environment. Learn more… Read More
The biotech “cluster” of East Cambridge has long been credited with supporting an industry collaboration and knowledge sharing environment not seen on this scale anywhere else, but where is the money Read More
